Fight Illicit Pill Presses Act
- Bill Number
- S. 2870
- Origin Chamber
- Senate
- Congress
- 119th Congress, Session 1
- Policy Area
- Crime and Law Enforcement
- Status
- Introduced
- Latest Action
- 2025-09-18: Read twice and referred to the Committee on the Judiciary.
- Last Updated
- 2026-07-01T20:08:59Z
AI-Generated Summary
Purpose
The "Fight Illicit Pill Presses Act" aims to combat the illegal production of counterfeit or illicit pills by requiring serial numbers on tableting machines (devices that compress powder into tablets) and encapsulating machines (devices that fill capsules with powder). This helps law enforcement track these machines, which are often used to manufacture fake prescription drugs containing dangerous substances like fentanyl.
Key Provisions
- Expanded Definitions: Updates the Controlled Substances Act (CSA) to broaden the term "regulated person" to include anyone who manufactures, distributes, imports, exports, or brokers tableting/encapsulating machines or their "critical parts" (key components like punches and dies, which are tools that shape tablets or capsules).
- Serial Number Requirement: Regulated persons must affix a permanent serial number (engraved, cast, or otherwise fixed to a non-removable part) to these machines and critical parts during manufacturing, distribution, delivery, sale, import, or export, as directed by the Attorney General.
- Record-Keeping and Reporting: Businesses must maintain records of transactions involving these machines or parts, including the serial number, and report them to the Attorney General.
- Regulations and Timeline: The Attorney General must issue detailed regulations within 180 days of enactment, including guidance for marking existing machines made before the law takes effect. The rules apply only to machines/parts handled after the regulations are finalized.
- Prohibited Acts: Makes it illegal to:
- Remove, alter, or destroy a required serial number on these machines or parts.
- Transport, possess, sell, or otherwise handle such items knowing their serial number has been tampered with.
These violations carry penalties under the CSA, similar to other drug-related offenses.
Significant Changes to Existing Law
- Definition Updates: Replaces and expands prior CSA definitions (e.g., "regulated person" and "regulated transaction") to explicitly cover tableting/encapsulating machines and critical parts, which were previously regulated but without mandatory serial numbering.
- New Enforcement Tools: Adds specific record-keeping, reporting, and anti-tampering rules that did not exist before, closing gaps in tracking equipment used for illicit drug production.
- Prohibitions: Introduces two new criminal offenses (removing serial numbers or dealing in tampered equipment), building on existing CSA bans related to listed chemicals (substances used in drug manufacturing).
Potential Impacts
- On Government Agencies: Enhances the Drug Enforcement Administration (DEA) and Attorney General's ability to trace machines linked to illegal operations, potentially improving investigations into fentanyl-laced pill trafficking. Requires regulatory updates and oversight of compliance.
- On Citizens: Could reduce the availability of illicit pills in communities by making it harder for criminals to anonymously acquire or modify production equipment, indirectly supporting public health efforts against the opioid crisis.
- On International Relations: May affect trade in these machines by imposing U.S. export/import reporting, potentially influencing relations with countries involved in chemical or equipment supply chains for drug production.
- Broader Economy: Legitimate pharmaceutical and manufacturing industries may face added compliance costs for serial numbering and reporting, though exemptions likely apply to approved medical uses.
Main Stakeholders Affected
- Manufacturers and Distributors: Companies producing or selling tableting/encapsulating machines or parts must implement serial numbering and reporting, increasing operational requirements.
- Law Enforcement and Regulators: DEA, Attorney General's office, and customs officials gain tools for better enforcement but must develop and enforce new regulations.
- Illicit Drug Producers: Underground operators face higher risks of detection and prosecution when using or modifying these machines.
- Legitimate Industries: Pharmaceutical firms and supplement makers using these machines for legal purposes will need to ensure compliance to avoid penalties.
- Consumers and Public Health Advocates: Benefit from reduced illicit drug supply, supporting efforts to address overdose deaths.
Notable Legal, Constitutional, or Political Implications
- Legal: Strengthens federal drug enforcement under the CSA by treating machines as trackable assets, similar to firearms serialization laws. Violations could lead to felony charges with fines or imprisonment, aligning with broader anti-trafficking efforts. Courts may see increased cases involving equipment forfeiture.
- Constitutional: No major challenges anticipated, as the law regulates commerce in controlled items (interstate trade), falling under Congress's commerce clause authority. It avoids direct speech or privacy issues by focusing on business transactions.
- Political: Bipartisan sponsorship (from senators across parties) reflects consensus on addressing the fentanyl epidemic. It builds on prior opioid legislation without controversial expansions like new taxes or mandates, potentially serving as a model for future anti-drug tech regulations.
This summary was generated by AI and may contain inaccuracies. Refer to the official source document for the authoritative text.
Sponsor
Cosponsors (13)
Sen. Coons, Christopher A. [D-DE], Sen. Moran, Jerry [R-KS], Sen. Fetterman, John [D-PA], Sen. Tillis, Thomas [R-NC], Sen. Klobuchar, Amy [D-MN], Sen. McCormick, David [R-PA], Sen. Gallego, Ruben [D-AZ], Sen. Cantwell, Maria [D-WA], Sen. Blackburn, Marsha [R-TN], Sen. Capito, Shelley Moore [R-WV], Sen. Cortez Masto, Catherine [D-NV], Sen. Hyde-Smith, Cindy [R-MS], Sen. King, Angus S., Jr. [I-ME]
Recent Actions
- 2025-09-18: Read twice and referred to the Committee on the Judiciary.
- 2025-09-18: Introduced in Senate
Bill Versions
- Fight Illicit Pill Presses Act — issued 2025-09-18 — PDF (6 pages)